Autoantibodies against heat shock protein 40 (HSP40) and their clinical significance in ulcerative colitis (UC) have not been evaluated before. Twenty-six tissue specimens of inflamed areas from patients with UC, 16 from patients with Crohn's disease (CD) and 16 endoscopically normal tissues were analysed for HSP40 expression. Sera from 47 patients with UC and 44 healthy volunteers were examined for the presence of autoantibodies against HSP40 by enzyme-linked immunosorbent assay test. Immunohistochemistry showed that 17 out of 26 specimens from UC patients, one specimen from a CD patient and one normal tissue specimen were positive for HSP40. Most HSP40-positive cells expressed CD68. Higher titres of anti-HSP40 autoantibodies were detected in sera from UC patients compared with healthy volunteers. In patients with inactive disease, those with proctitis or left-sided colitis had higher titres of anti-HSP40 autoantibodies than those with total colitis. Our study suggests that autoimmunity against HSP40 may have a beneficial effect in UC patients by limiting the extent of the disease.
Introduction
In order to distinguish pathogenic antigens from dietary ones or normal flora (due to the vast numbers of antigens passing through the intestinal lumen), the immune system in the intestinal mucosa must be carefully regulated. The exact pathogenesis of inflammatory bowel disease (IBD) is still unknown, possibly because of its intrinsic complexity; deregulated immune responses, however, seem to play a key role in sustaining the inflammatory reactions that lead to tissue destruction in the inflamed areas. 1 The fact that intestinal inflammation is observed in mice with disruptions in the genes encoding cytokines or the T-cell receptor (TCR) α-chain supports this hypothesis. 2 The autoantibodies detected in the sera from IBD patients may result from perturbations of the intestinal immune system. Of these autoantibodies, perinuclear anti-neutrophil cytoplasmic antibody (pANCA) has been most extensively analysed in ulcerative colitis (UC) patients. Over 70% of UC patients have the pANCA autoantibody in their sera, and the antigen that it recognizes is thought to be different to the one recognized by the pANCA autoantibody detected in vasculitis diseases such as Wegener's granuloma. 1, 3 As pANCA is detected in few patients with Crohn's disease (CD) and titres of this autoantibody do not correlate with the disease activity, extent or duration of UC, 3 pANCA may be a useful disease marker for UC.
Heat shock proteins (HSPs), whose functions are folding and translocation of proteins inside cells, are upregulated to protect the host cells from stress evoked by infections and inflammations. 4 As a result of their abundance under such conditions and high homology with their microbial counterparts, humoral or cellular immune responses to major HSPs, such as HSP60 or HSP70, have been reported in various infectious and autoimmune diseases including IBD, although the clinical significance of autoimmunity against major HSPs remains unclear. 5 HSP40 functions as a co-chaperone of HSP70 and has recently been shown to be related to double-stranded RNA-dependent protein kinase. 6, 7 Mammalian HSP40 is less homologous to microbial counterparts than major HSPs, so immune reactions against HSP40 have not been extensively investigated. In IBD patients we investigated HSP40 expression in tissue samples and the immunoreactivity of sera to HSP40. We then analysed the relevance of autoimmunity against HSP40 to the clinical features observed in patients with UC.
Patients and methods

PATIENTS
The study was conducted according to the ethical standards of Nagasaki University School of Medicine and was performed with patients' written informed consent. Patients with UC or CD and healthy volunteers were consecutively selected at Nagasaki University Hospital and enrolled in this study. None of the patients had clinically apparent autoimmune and/or infectious diseases. We made a diagnosis of UC and assessed the extent of disease activity based on previously reported criteria. 8, 9 SERA AND TISSUE SPECIMENS Sera were obtained from all patients at the time of diagnosis. Tissue samples were obtained using forceps during endoscopic examination.
MEASUREMENT OF ANTI-HEAT SHOCK PROTEIN AUTOANTIBODIES IN SERA
Details of human recombinant HSP40 and its rabbit polyclonal antibody are described elsewhere. 10, 11 We confirmed that this polyclonal antibody did not cross-react with DnaJ, an Escherichia coli homologue to mammalian HSP40, by enzyme-linked immunosorbent assay (ELISA). Recombinant mammalian HSP70 and monoclonal antibody (mAb) against HSP70 were purchased from StressGen (Victoria, Canada).
To detect anti-HSP autoantibodies, 10 µg/ml recombinant HSP solution dissolved in coating buffer was added to each well in 96-well flat-bottomed plates. After incubation at room temperature for 1 h, the plates were washed extensively and blocked with 1% bovine serum albumin in physiological saline for 5 min. After washing, sera diluted at 1:200 were added to each well and incubated for 1 h. Following the reaction with the patients' sera, all procedures were carried out according to the manufacturer's protocol using ELISAmate (Kirkegaard & Perry, Gaithersburg, MD, USA). The optical density (OD) of serum samples was measured at 405 nm with a MR600 microplate reader (Dynatech, Alexandria, VA, USA).
TISSUE PREPARATION AND HISTOLOGICAL EXAMINATION
Tissue specimens were fixed with buffered formalin and embedded in paraffin. Tissue sections (thickness, 5 µm) were placed on glass slides and the paraffin was removed with xylene and ethanol. Standard haematoxylin and eosin staining was applied to all samples.
IMMUNOHISTOCHEMISTRY
For single staining of HSP40, rabbit polyclonal antibody against mammalian HSP40 at a dilution of 1:500 was added and incubated overnight at room temperature. Following washing, 10 mg/ml of alkaline phosphatase-labelled anti-rabbit IgG was added and incubated for 20 min. Fukusin (Nichirei, Tokyo, Japan) was used as a substrate. For double staining, HSP40 staining was done as described above and then mouse anti-human CD68 (Dako, Glostrup, Denmark) at a dilution of 1:100 was added and incubated in a moist chamber for 4 h. After washing, 10 mg/ml peroxidase-labelled anti-mouse IgG was added and incubated for 20 min. True Blue (Kirkegaard & Perry, Gaithersburg, MD, USA) was used as a substrate. All slides were evaluated separately in a blinded manner by two pathologists.
STATISTICAL ANALYSIS
Two pathologists independently interpreted the immunohistochemical staining of HSP40. The differences among UC patients, CD patients and healthy volunteers were evaluated by Fisher's exact test using the Bonferroni procedure. The OD values of antibodies against HSP40 or HSP70 were expressed as the median, with 25th and 75th percentile values (median [25th, 75th percentiles]). The differences between UC patients and healthy volunteers or between active and inactive UC were evaluated by the Mann-Whitney U-test. The relationship between antibodies against HSP40 and those against recombinant DnaJ was assessed by Spearman correlation. Two-tailed P < 0.05 was considered statistically significant. Data were analysed with the StatView ® software program (version 5.0; SAS Institute Inc., Cary, NC, USA). 
Results
PATIENTS
SPECIFIC EXPRESSION OF HEAT SHOCK PROTEIN 40 IN INFLAMED AREAS OF ULCERATIVE COLITIS
Twenty-six tissue specimens from inflamed areas in patients with UC, 16 from patients with CD and 16 from areas that appeared normal when viewed via an endoscope were taken and analysed for the expression of HSP40, HSP70 and CD68. Figure 1A shows the histological changes typical of UC. HSP40-positive cells were scattered ( Fig. 1B) and most of them expressed CD68 ( Figs 1C and 1D ), suggesting that cells that have an antigen-presenting function over-express HSP40 or phagocytose apoptosed cells expressing HSP40. CD68expressing cells were also positive for HLA class II expression (data not shown). A high proportion of specimens from patients with UC were positive for HSP40 expression (17 out of 26), compared with 1 out of 16 specimens from patients with CD and 1 out of 16 normal specimens that were weakly positive ( Table 2 ). These findings suggest that HSP40 expression was elicited under deregulated immunological and inflammatory reactions specific for UC. HSP70 was expressed ubiquitously in epithelial cells and 
AUTOANTIBODIES AGAINST HEAT SHOCK PROTEINS 40 AND 70 IN SERA FROM PATIENTS WITH ULCERATIVE COLITIS
The high proportion of HSP40 expression in UC motivated us to investigate the presence of autoantibodies against HSP40. Sera samples from 44 healthy volunteers (controls) and 57 sera samples from 47 UC patients who had active and/or inactive UC were evaluated for immunoreactivity against HSP40 and HSP70 by ELISA. As expected, no significant difference in the IgG titres against HSP70 was observed between UC patients and healthy controls ( Fig. 2A) . Higher IgG immunoreactivity against HSP40 was, however, detected in sera from UC patients compared with healthy controls (Fig. 2B ). Higher titres of anti-HSP40 IgA antibody were also seen in UC patients compared with healthy controls.
Sera from patients with CD had no immunoreactivity against HSP40 and HSP70 (data not shown). There was no correlation between the titres against mammalian HSP40 and DnaJ (data not shown), indicating no cross-reactivity of anti-mammalian HSP40 autoantibodies with DnaJ.
CLINICAL IMPLICATIONS OF AUTO-ANTIBODIES AGAINST HEAT SHOCK PROTEIN 40 IN ULCERATIVE COLITIS
To evaluate the biological significance of anti-HSP40 IgG autoantibodies, we classified UC patients according to the activity or extent of the disease and then compared the titres of autoantibodies against HSP40 in each group. As shown in Fig. 3A , no significant difference was seen between the active and inactive diseases. Among patients with inactive UC, significantly higher titres against HSP40 were observed in patients with limited disease (proctitis and left-sided colitis) than in those patients with total colitis (median [25%, 75%]: 238 [210, 300] versus 214 [171, 283], respectively; *P < 0.05) (Fig. 3B ).
Discussion
To consider the involvement of HSPs in organspecific autoimmune responses, it is essential to confirm the expression of HSPs in target organs and to detect autoantibodies or T-cells specific for the corresponding HSPs, which are usually harmful to the tightly regulated and integrated functions of target organs. 5 Based on our findings in this study, it is reasonable to regard the immune responses to HSP40 observed in a subset of our UC patients as autoimmunity. It is well known that apoptotic cells are a major source of self-antigens, 12 and apoptosis of epithelial cells in inflamed areas of UC has been previously reported. 13 We therefore speculated that damaged epithelial cells transiently over-expressing HSP40 undergo apoptosis and are then engulfed by CD68-positive cells. The possibility that CD68-positive cells overexpress HSP40 under stressful conditions cannot, however, be excluded. Even selfantigens, when exogenously added to antigen-presenting cells (such as dendritic cells), have been shown to be properly processed and antigen peptides presented with major histocompatibility (MHC) class I or II molecules thereby priming and activating naïve T-cells. 14, 15 Auto-reactive T-cells are thought to be eliminated by activationinduced cell death in which IL-2 plays an important role. 16, 17 Under the local immunological circumstances favourable for inducing autoimmune reactions such as sustained inflammation, 18 activation-induced cell death may not be evoked effectively, which allows auto-reactive T-cells to survive.
Our current hypothesis regarding the generation of anti-HSP40 autoantibodies in some UC patients is that HSP40-specific CD4 T-cells survive activation-induced cell death and then assist in the generation of autoantibodies against HSP40 through the interaction with activated B-cells. To do this, the CD4 T-cells are primed with antigen peptides derived from phagocytosed HSP40 and presented with appropriate MHC class II molecules.
The absence of B-cells exacerbates clinical courses of autoimmune diseases in some animal models. B-cell-deficient B10.PLµMT mice, produced by the disruption of the µ-heavy chain transmembrane exon, were challenged with a pathogenic peptide from myelin basic protein. The incidence rate of autoimmune encephalitis in B10.PLµMT mice was the same as wild-type mice, but in contrast the B-celldeficient mice never recovered from the disease. 19 In experimental models of IBD, TCR α-chain and Ig µ-chain double-deficient mice showed much more severe colitis than TCR α-chain-deficient mice. 20 An important finding in this report was that passive transfer of purified immunoglobulins from TCR α-chain-deficient mice or a mixture of mAbs against colon epithelial antigens, decreased the number of apoptotic cells and reduced the severity of colitis in double-knockout mice. The implication from these studies is that humoral immunity may provide beneficial effects on the clinical courses of some autoimmune diseases, although it does not prevent the occurrence of these diseases.
Autoantibodies were reported to play pivotal roles in the clearance of apoptotic cells, which resulted in reducing circulating autoantigens and autoreactive T-cells in autoimmune animal models. 20, 21 Although we do not have any direct evidence for the beneficial effects of autoantibodies against HSP40 on the clinical features of UC, statistical analysis implies that the presence of these autoantibodies affected the extent of the disease in some UC patients. The assumption from this analysis is that HSP40 is one of the major self-antigens in UC and that clearance of HSP40 by autoantibodies may have some impact on the pathological changes of the disease. More evidence is required to verify the biological and clinical significance of 
